OnQ Prostate

Study: RSI is a novel diffusion-weighted MRI technique being used in prostate MRI to highlight key aspects of tissue microarchitecture with high conspicuity.

Study: Comparison of the diagnostic performance of RSI versus that of conventional multi-parametric magnetic resonance imaging for prostate cancer.

Study: Performance evaluation of Restriction Spectrum Imaging (RSI-MRI), a novel MRI technique for quantitatively detecting/grading PCa.

Study: Physical foundations and applications of Restriction Spectrum Imaging: a detailed explanation of the biophysical basis of diffusion contrast.

At RSNA 2021, Dr. Tyler Seibert MD, PhD will present new findings regarding the use of Quantitative MRI for prostate cancer detection and monitoring.

Two federal awards will fund the development of advanced AI tools used to help predict and manage care of clinically significant prostate and brain cancer.

OnQ Prostate uses an advanced diffusion-weighted magnetic resonance imaging technique to “highlight” areas with the cellular characteristics of cancer.

Imaging Healthcare Specialists partners with Cortechs.ai to provide the latest advancement in diffusion MRI by integrating OnQ Prostate.